Journal article

Immediate outcomes following the GLA:D (R) program in Denmark, Canada and Australia. A longitudinal analysis including 28,370 patients with symptomatic knee or hip osteoarthritis

EM Roos, DT Gronne, ST Skou, MG Zywiel, R McGlasson, CJ Barton, JL Kemp, KM Crossley, AM Davis

OSTEOARTHRITIS AND CARTILAGE | ELSEVIER SCI LTD | Published : 2021

Abstract

OBJECTIVE: To report outcomes across three countries for patients with symptomatic knee or hip OA attending the evidence-based education and exercise therapy program Good Life with osteoArthritis from Denmark (GLA:D®). DESIGN: GLA:D® is a structured treatment program including 2-3 patient education sessions and 12 supervised exercise sessions delivered over 8 weeks by certified health care practitioners. The program was introduced in Denmark in 2013, in Canada 2015 and in Australia 2016. Absolute mean change in pain intensity, number of chair stands in 30 s, 40 m walk test time and Knee injury and Osteoarthritis Outcome Score (KOOS)/Hip dysfunction and Osteoarthritis Outcome Score (HOOS) QOL..

View full abstract

Grants

Awarded by European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program


Awarded by National Health and Medical Research Council Australia Early Career Fellowship


Awarded by Medical Research Future Fund Translation of Research Into Practice Fellowship


Funding Acknowledgements

The initiation of GLA:D (R) Denmark was partly funded by the Danish Physiotherapy Association's fund for research, education and practice development; the Danish Rheumatism Association; and the Danish Physiotherapy Practice Foundation. Dr. Skou is currently funded by a grant from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No 801790) and a program grant from Region Zealand (Exercise First).GLA:D (R) Canada The initiation of GLA:D Canada was supported by a grant from the Ontario Trillium Foundation. No external funding was received specific to this work.GLA:D (R) Australia has no external funding support. Dr Kemp is supported by a National Health and Medical Research Council Australia Early Career Fellowship (1199971). Dr Barton is supported by a Medical Research Future Fund Translation of Research Into Practice Fellowship (1150439).